184
Participants
Start Date
February 28, 2011
Primary Completion Date
June 30, 2012
Study Completion Date
August 31, 2016
MiStent DES
The MiStent is a device/drug combination comprised of two components; a stent and a drug product (sirolimus within an absorbable polymer coating).
Endeavor DES
The Endeavor is a device/drug combination comprised of two components; a stent and a drug product (everolimus within a durable polymer coating).
Cardiovascular Center, Aalst
Antwerp Hospital, ZNA Middelheim, Antwerp
Brussels University Hospital, Brussels
Ziekenhuis Oost-Limburg, Genk
Virga Jesse Ziekenhuis, Hasselt
KUL Cardiology Gasthuisberg, Leuven
Jacques Cartier Hospital, Massy
Claude Galien Hospital, Quincy
Clinique Pasteur, Toulouse
OLV, Amsterdam
St. Antonius Ziekenhuis, Nieuwegein
TweeSteden Ziekenhuis, Tilburg
UMC Utrecht, Utrecht
Hospital Weezenlanden, Zwolle
Auckland City Hospital, Auckland
Mercy Angiography Unit, Auckland
Christchurch Hospital, Christchurch
Dunedin Hospital, Dunedin
Wellington Hospital, Wellington
Sahlgrenska University Hospital, Gothenburg
Orebro University Hospital, Örebro
Royal Sussex Hosp, Brighton
Papworth Hospital, Cambridge
Guy's & St. Thomas', London
Royal Brompton, London
University Hospital South Manchester, Manchester
Norfolk/Norwich UHosp, Norwich
Southampton UHT, Southampton
Lead Sponsor
Micell Technologies
INDUSTRY